Search for: "OMNICARE, INC."
Results 161 - 180
of 291
Sort by Relevance
|
Sort by Date
23 Apr 2014, 8:50 am
Busk, 13-433 (granted at the February 28 Conference, relisted once); Omnicare, Inc. v. [read post]
6 Apr 2014, 2:27 pm
Referring to the Delaware Supreme Court decision in Omnicare, Inc. v. [read post]
18 Mar 2014, 10:37 am
That is the question taken up by the Supreme Court earlier this month when it granted certiorari in Omnicare, Inc. v. [read post]
5 Mar 2014, 6:25 am
Omnicare, Inc. [read post]
3 Mar 2014, 7:06 am
Omnicare, Inc. v. [read post]
28 Feb 2014, 6:43 am
Omnicare, Inc., a decision having significant repercussions for the pharmaceutical industry and broader FCA jurisprudence. [read post]
28 Feb 2014, 6:31 am
Omnicare, Inc., No. 12-2431, 2014 WL 661351 (4th Cir. [read post]
27 Feb 2014, 1:42 pm
Omnicare, Inc. v. [read post]
27 Feb 2014, 11:23 am
Omnicare, Inc., No. 12-2431, the Fourth Circuit affirmed the dismissal of a relator’s FCA complaint (and denied leave to amend) under Fed. [read post]
24 Feb 2014, 10:38 pm
Omnicare, Inc., a qui tam case brought in Maryland by a former employee of the long-term care pharmacy company, Omnicare. [read post]
24 Feb 2014, 7:36 pm
Omnicare, Inc. v. [read post]
22 Feb 2014, 2:32 am
At its Friday conference, the Supreme Court considered the cert petition filed in Omnicare, Inc. v. [read post]
14 Feb 2014, 12:00 pm
Hoosier Energy Rural Electric Cooperative, Inc. v. [read post]
6 Feb 2014, 7:41 pm
The petition of the day is: Omnicare, Inc. v. [read post]
8 Nov 2013, 12:51 pm
This week, the Justice Department announced the conclusion of an 8-year-long civil False Claims Act case against Johnson & Johnson and its subsidiary Scios, Inc. [read post]
4 Nov 2013, 9:56 pm
”J&J Subsidiary Janssen Pleads Guilty to Misbranding Antipsychotic DrugIn a criminal information filed today in the Eastern District of Pennsylvania, the government charged that, from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. [read post]
4 Nov 2013, 2:36 pm
In addition, with the hope of increasing their drug market share among elderly patients, J&J and Janssen allegedly paid millions of dollars in kickbacks to Omnicare Inc., the nation’s largest pharmacy specializing in dispensing drugs to nursing home patients. [read post]
4 Nov 2013, 3:04 am
On November 4, the Department of Justice announced that Johnson & Johnson and its subsidiaries, Janssen Pharmaceuticals, Inc., and Scios, Inc., had agreed to pay $2.2 billion to resolve claims originally brought by whistleblowers that the company promoted its drugs Risperdal, Invega, and Natrecor for unapproved (off-label) uses. [read post]
29 Oct 2013, 9:00 am
Omnicare Inc., the nation's largest dispenser of prescription drugs in nursing homes, announced on October 23, 2013, that it has agreed to pay $120 million to settle a whistleblower lawsuit alleging kickbacks to nursing homes. [read post]
23 Oct 2013, 4:17 am
On October 23, the long-term care pharmacy giant Omnicare, Inc., filed an 8-K statement with the SEC disclosing that it had reached an agreement in principle to settle allegations of kickbacks raised by a qui tam relator in the Northern District of Ohio, for $120 million. [read post]
